-
Labial HSV is a remarkably common infection, and is now believed to infect ~70% of the population in the U.S.. Many of these people have only an infrequent outbreak or are unaware of their latent infection.
-
In this issue: New treatment for prostate cancer; avastin and breast cancer; new CMS disclosure rule; and FDA actions.
-
-
To examine the association between being placed in contact isolation and delirium, Day and colleagues at the University of Maryland Medical Center reviewed administrative data on all patients admitted during a 2-year period ending in 2009.
-
The increasing prevalence of antibiotic resistance in urinary pathogens has led Hooton and colleagues to examine the efficacy of a relatively broad spectrum orally administered cephalosporin in the treatment of uncomplicated cystitis.
-
-
Garbutt and colleagues performed a randomized placebo controlled trial designed to evaluate the efficacy of antibiotic therapy in patients with a clinical diagnosis of acute rhinosinusitis at 10 primary care practices in St. Louis.
-
The concern regarding influenza infection is high in cancer patients since the rate of infection is considerably higher and mortality is four times greater than in the general population.
-
Trying to rein in the widespread misuse of antibiotics that is driving the rise of pan-resistant infections, the Centers for Disease Control and Prevention has created an electronic tracking system that will allow hospitals to monitor and benchmark drug use much as they already do for health care associated infections (HAIs).
-
As a key complement to its new antibiotic use tracking system, the Centers for Disease Control and Prevention is partnering with the Institute for Healthcare Improvement (IHI) in a pilot program to prevent overuse and misuse of antibiotics in hospitals.
